Analytical companies predict that the pharmaceutical market will show a positive trend in 2017. A favorable business-climate and investment attractiveness of the industry are due to the stabilization of the political situation in the USA.
The pharmaceutical business in Russia is also demonstrating a promising growth. In 2016 the sales has increased by 20%. After important industry-specific solutions, the structure of the commercial market of medications has also changed. In September 2016, the industry underwent significant changes as compared to the same period of 2015: the share of medicines with an average cost of packaging has increased, at the same time the share of expensive medications has reduced while the average cost of packaging has gone up. Following the results of September 2016, the study showed that slightly more than a half of medicines in packs sold in the marker are domestic.
In the framework of the forum organized by business daily Vedomosti together with Kaluga Region Government, Agency for innovation development – center for cluster development of Kaluga region with the support of Kaluga Pharmaceutical Cluster, the discussion of industry perspective development will take place.
Key issues:
Audience 200+
The event will bring together key players of the market: representatives and heads of federal governmental institutions and regional authorities, the biggest pharmaceutical companies, research and innovative business incubators, distribution centers and pharmacy chains, industry associations, unions, funds, management companies and major analysts, investors, experts and mass media.
The project of the programme
10:00 – 11:00. Registration, welcome coffee
11:00 – 13:00. Discussion session 1. A pharmaceutical cluster as an investment driver of the industry development
Key issues:
Invited participants:
Anatoly Artamonov, Governor of Kaluga Region*
Zakhar Golant, Chairman of the Board, Union of Pharmaceutical and Biomedical Clusters
Ivan Glushkov, President of the Board, Kaluga Pharmaceutical Cluster*
Igor Kagramanyan, Deputy Minister of Healthcare of the Russian Federation
Juergen Koenig, President and General Director, Merck Russia & CIS
Oleg Korzinov, Executive Director, Development Center Biopharmcluster “Severniy”
Anna Mityanina, Vice-Governor of St.Petersburg
Sergey Nazarov, Deputy Minister of Economic Development of the Russian Federation
Iskra Reich, Vice-President Russia & Eurasia, AstraZeneca
Peter Rodionov, CEO, Geropharm
Sergey Tsib, Deputy Minister of Industry and Trade of the Russian Federation*
13:00 – 14:00. Lunch
14:00 – 15:30. Discussion session 2. New Russian pharma: wonder or a perspective reality
Key issues:
Invited participants:
Victor Dmitriyev, CEO, ARFP (Association of Russian pharmaceutical manufacturers)
Andrey Ivaschenko, Chairman of the Board of Directors, Chemrar
Olga Kolotilova, Director of the Department for Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade of the Russian Federation
Dmitry Kudlay, CEO, Generium
Elena Maksimkina, Director of the Department for Medicinal Drug Supply and Regulation of Medical Devises Circulation, Ministry of Healthcare of the Russian Federation
Alexander Malin, CEO, Nativa
14:00 – 15:30. Discussion session 2.2. Pricing and new procurement models
Key issues:
Invited participants:
Konstantin Baranov, Minister of Healthcare of Kaluga Region
Elena Maksimkina, Director of the Department for Medicinal Drug Supply and Regulation of Medical Devises Circulation, Ministry of Healthcare of the Russian Federation
Timofey Nizhegorodtsev, Head of the Department for Control over Social Sphere and Trade, Federal Antimonopoly Service of the Russian Federation
Vitaly Omelyanovskiy, CEO, Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation
Daria Starykh, Head of the Division for Regulating Pharmaceutical Prices, Federal Antimonopoly Service of the Russian Federation
Sergey Shulyak, CEO, DSM Group
Alexander Kholopov, Head of the Department for Healthcare, Tomsk Region
15:30 – 16:00. Coffee break
16:00 – 17:30. Discussion session 3. Digital in pharmacy and medicine
Key issues:
Invited participants:
Grigory Bakunov, Director of Spreading Technology, Yandex
Kirill Varlamov, Director, Internet Initiatives Development Fund
Ruslan Zaydullin, Cofounder and CEO, DOC+*
Maria Izmestieva, Director of Innovative Projects, Teva
German Klimenko, Presidential Internet Adviser, Presidential Administration of Russia
Mikhail Konovalov, Head of IT CIS, Bayer
Leonid Levin, Chairman of the Committee on Information Policy, Information Technology, and Communications, State Duma of the Russian Federation
Mikhail Murashko, Head of the Federal Service for Supervision of Healthcare of the Russian Federation
Konstantin Solodukhin, CEO, National Center of Informatization (NIC)
17:30 – The end of the forum. Evening cocktail.
*confirmed speakers
Production placement application
Establishment of industrial parks with high quality sites with all relevant utilities for new plants construction ensures well-balanced distribution of industrial facilities throughout the region with due consideration of transport, utilities and social infrastructure development and future labor resources development.
If you are interested in placement of a production facility at an investment site, please fill in the online application form.
Thank you!
You successfully subscribed to news digest
Thank you!
Your message has been sent.
error
Error!